Lindholm LH - Search Results

1

From efficacy in trials to effectiveness in clinical practice: The Swedish Stroke Prevention Study.

Brunström M, Dahlström J, Lindholm LH, Lönnberg G, Hallström S, Norberg M, Nyström L, Persson M, Weinehall L, Carlberg B. Brunström M, et al. Among authors: lindholm lh. Blood Press. 2016 Aug;25(4):206-11. doi: 10.3109/08037051.2015.1127556. Epub 2016 Feb 8. Blood Press. 2016. PMID: 26854107 Free article.

2

Stroke and blood-pressure variation: new permutations on an old theme.

Carlberg B, Lindholm LH. Carlberg B, et al. Among authors: lindholm lh. Lancet. 2010 Mar 13;375(9718):867-9. doi: 10.1016/S0140-6736(10)60351-0. Lancet. 2010. PMID: 20226970 No abstract available.

3

The new Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014): a giant undertaking.

Lindholm LH, Carlberg B. Lindholm LH, et al. Hypertens Res. 2014 Apr;37(4):391-2. doi: 10.1038/hr.2014.21. Hypertens Res. 2014. PMID: 24705437 No abstract available.

4

Association of Physician Education and Feedback on Hypertension Management With Patient Blood Pressure and Hypertension Control.

Brunström M, Ng N, Dahlström J, Lindholm LH, Lönnberg G, Norberg M, Nyström L, Weinehall L, Carlberg B. Brunström M, et al. Among authors: lindholm lh. JAMA Netw Open. 2020 Jan 3;3(1):e1918625. doi: 10.1001/jamanetworkopen.2019.18625. JAMA Netw Open. 2020. PMID: 31913490 Free PMC article.

5

Association of education and feedback on hypertension management with risk for stroke and cardiovascular disease.

Brunström M, Ng N, Dahlström J, Lindholm LH, Norberg M, Nyström L, Weinehall L, Carlberg B. Brunström M, et al. Among authors: lindholm lh. Blood Press. 2022 Dec;31(1):31-39. doi: 10.1080/08037051.2022.2041393. Blood Press. 2022. PMID: 35179089 Free article.

6

Atenolol in hypertension: is it a wise choice?

Carlberg B, Samuelsson O, Lindholm LH. Carlberg B, et al. Among authors: lindholm lh. Lancet. 2004 Nov 6-12;364(9446):1684-9. doi: 10.1016/S0140-6736(04)17355-8. Lancet. 2004. PMID: 15530629

7

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Lindholm LH, Carlberg B, Samuelsson O. Lindholm LH, et al. Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3. Lancet. 2005. PMID: 16257341 Review.

8

Beta blockers in primary hypertension: Do age and type of beta-blocker matter?

Lindholm LH, Carlberg B, Samuelsson O. Lindholm LH, et al. J Hypertens. 2006 Nov;24(11):2143-5. doi: 10.1097/01.hjh.0000249686.65994.97. J Hypertens. 2006. PMID: 17053530 Review. No abstract available.

9

High remaining risk in poorly treated hypertension: the 'rule of halves' still exists.

Weinehall L, Ohgren B, Persson M, Stegmayr B, Boman K, Hallmans G, Lindholm LH. Weinehall L, et al. Among authors: lindholm lh. J Hypertens. 2002 Oct;20(10):2081-8. doi: 10.1097/00004872-200210000-00029. J Hypertens. 2002. PMID: 12359988

10

Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample.

Persson M, Carlberg B, Weinehall L, Nilsson L, Stegmayr B, Lindholm LH. Persson M, et al. Among authors: lindholm lh. J Hypertens. 2003 Jun;21(6):1089-95. doi: 10.1097/00004872-200306000-00008. J Hypertens. 2003. PMID: 12777945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters